6533b7dafe1ef96bd126d8ae
RESEARCH PRODUCT
Abacavir Increases Purinergic P2X7 Receptor Activation by ATP: Does a Pro-inflammatory Synergism Underlie Its Cardiovascular Toxicity?
Víctor Collado-díazMaria ÁNgeles Martinez-cuestaMaria ÁNgeles Martinez-cuestaMaria Amparo Blanch-ruizAinhoa Sánchez-lópezPatricia García-martínezJosé E PerisIris UsachMaria Dolores IvorraAlessandra LaceteraSonsoles Martín-santamaríaJuan V. EspluguesJuan V. EspluguesJuan V. EspluguesAngeles AlvarezAngeles Alvarezsubject
0301 basic medicineAgonistAllosteric modulatormedicine.drug_classAllosteric modulatoradenosine triphosphateAllosteric regulationPharmacologyleukocyte-endothelium interactionsProinflammatory cytokine03 medical and health scienceschemistry.chemical_compound0302 clinical medicineimmune system diseasesAbacavirmedicinePharmacology (medical)Original ResearchPharmacologyApyraseLeukocyte-endothelium interactionsabacavirlcsh:RM1-950Purinergic receptorallosteric modulatorvirus diseasesAbacavircardiovascular diseasesCardiovascular diseaseslcsh:Therapeutics. Pharmacology030104 developmental biologychemistryP2X7 receptorAdenosine triphosphate030217 neurology & neurosurgeryAdenosine triphosphatemedicine.drugdescription
16 p.-9 fig.-1 tab.
year | journal | country | edition | language |
---|---|---|---|---|
2021-03-31 | Frontiers in Pharmacology |